ASND - CIK 0001612042
Ascendis Pharma A/S has filed 763 documents with the SEC between 2014 and 2026. The most frequent type is 6-k (411 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SD | - | 2026-05-22 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| 6-K | - | 2026-05-13 | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-11 | - |
| SCHEDULE 13G/A | - | 2026-05-07 | - |
| SCHEDULE 13G | - | 2026-05-07 | - |
| 6-K | - | 2026-05-07 | 2026-03-31 |
| 6-K | - | 2026-05-07 | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| 6-K | - | 2026-04-21 | 2026-04-21 |
| 6-K | - | 2026-04-21 | 2026-04-21 |
| 8-A12B/A | - | 2026-04-20 | - |
| 6-K | - | 2026-04-20 | 2026-04-20 |
| 6-K | - | 2026-04-16 | 2026-04-15 |
| 6-K | - | 2026-04-08 | 2026-04-08 |
| 6-K | - | 2026-04-08 | 2026-04-08 |
| 6-K | - | 2026-04-07 | 2026-04-06 |
| New insider ownership | 3 | 2026-04-01 | 2026-03-23 |
| 6-K | - | 2026-03-30 | 2026-03-30 |
| 6-K | - | 2026-03-24 | 2026-03-24 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| 6-K | - | 2026-03-17 | 2026-03-17 |
| 6-K | - | 2026-03-16 | 2026-03-16 |
| 6-K | - | 2026-03-11 | 2026-03-11 |
| Insider sale notice | 144 | 2026-03-09 | - |
| Insider sale notice | 144 | 2026-03-06 | - |
| 144/A | - | 2026-03-06 | - |
| Insider sale notice | 144 | 2026-03-05 | - |
| Insider sale notice | 144 | 2026-03-05 | - |
| Insider sale notice | 144 | 2026-03-05 | - |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider sale notice | 144 | 2026-03-02 | - |